Photodynamic Oncotherapy Mediated by Gonadotropin-Releasing Hormone Receptors

J Med Chem. 2017 Oct 26;60(20):8667-8672. doi: 10.1021/acs.jmedchem.7b01216. Epub 2017 Oct 10.

Abstract

Here, we report photodynamic oncotherapies mediated by gonadotropin-releasing hormone (GnRH) receptors. We synthesized conjugates 1 and 2 by coupling zinc phthalocyanine (ZnPc) to GnRH analogues. Compared to unmodified ZnPc, conjugates 1 and 2 exhibited higher and more specific phototoxicities to breast cancer cells. Furthermore, the two conjugates demonstrated excellent antitumor efficacies in a breast cancer-grafted animal model. Biodistribution study suggested the high biosafety of conjugate 2 because of the low retention in brain and skin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cell Line, Tumor
  • Female
  • Fluorescence
  • Gonadotropin-Releasing Hormone / physiology*
  • Humans
  • Mice
  • Microscopy, Confocal
  • Photochemotherapy*
  • Xenograft Model Antitumor Assays

Substances

  • Gonadotropin-Releasing Hormone